Skip to main content
Eric Winer, MD, Oncology, New Haven, CT

EricP.WinerMD

Oncology • New Haven, CT

Director, Yale Cancer Center Physician-in-Chief, Smilow Cancer Hospital

Join to view full profile

Dr. Winer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Winer's full profile

Already have an account?

  • Office

    35 Park Street
    New Haven, CT 06510
    Phone+1 617-632-6876
    Fax+1 617-632-1930

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1989
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Internal Medicine, 1983 - 1984
  • Yale School of Medicine
    Yale School of MedicineClass of 1983

Certifications & Licensure

  • ME State Medical License
    ME State Medical License Current
  • CT State Medical License
    CT State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 1997 - 2023
  • NC State Medical License
    NC State Medical License 1987 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Boston Magazine Castle Connolly, 2008-2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer  
    Eric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
  • Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer  
    Sara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
  • Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 Study  
    M C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
  • Join now to see all

Lectures

  • Breast Cancer, New Horizons, Current Controversies 
    Harvard Medical School, Boston, Massachusetts - 7/11/2013
  • 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS) 
    UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
  • Breast Cancer, New Horizons, Current Controversies 
    Harvard Medical School, Boston, Massachusetts - 7/12/2012

Press Mentions

  • Dr. Veda Giri on Yale Cancer Answers: A Rise in Early Onset Cancers: What Does It Mean?
    Dr. Veda Giri on Yale Cancer Answers: A Rise in Early Onset Cancers: What Does It Mean?October 28th, 2024
  • Telehealth Is Just as Effective as in-Person Care, Study Finds
    Telehealth Is Just as Effective as in-Person Care, Study FindsOctober 23rd, 2024
  • In Memoriam: Peter E. Schwartz, MD
    In Memoriam: Peter E. Schwartz, MDOctober 21st, 2024
  • Join now to see all

Grant Support

  • Clinical Studies CoreNational Cancer Institute2008–2009
  • Cancer And Leukemia Group BNational Cancer Institute2006–2008
  • C-2: Clinical Study CoreNational Cancer Institute2005–2007
  • Psychosocial Outcomes/Health Behaviors: Women With DCISNational Cancer Institute2000–2002
  • Tailored Information Materials About BRCA1 TestingNational Cancer Institute1995–1996

Professional Memberships

Dr. Eric Winer, Dr. Eric Winer, MD, Dr. E Winer, Dr. Eric P. Winer